WHO pandemic treaty talks stall
- WHO member states in Geneva failed on May 1 to finish the pandemic agreement’s pathogen-sharing annex, so the treaty adopted in 2025 still cannot open. - The fight is over PABS — the system linking pathogen samples and sequence data to vaccines, tests and treatments, plus how benefits get shared back. - That matters because the treaty was meant to fix COVID-era vaccine inequity, but its core enforcement piece is still missing.
Pandemic treaty talks did not exactly collapse last week. The stranger truth is that the treaty already exists, but the part that makes it work still doesn’t. In Geneva on May 1, WHO member states said they needed more time to finish the pathogen access and benefit-sharing annex — the bit that decides how countries share dangerous samples and what they get back. Until that annex is done, the 2025 WHO Pandemic Agreement is basically stuck in limbo. (who.int) ### Wait — wasn’t the treaty already adopted? Yes. The World Health Assembly adopted the WHO Pandemic Agreement by consensus on May 20, 2025, after more than three years of negotiations that started in the wake of COVID-19. But negotiators carved out one unresolved piece for later — the Pathogen Access and Benefit-Sharing system, usually shortened to PABS. (who.int) ### What is PABS, in plain English? It is the trade at the center of pandemic preparedness. If a country detects a dangerous new virus, the world wants that country to quickly share samples and genetic sequence data so labs and drugmakers can build tests, vaccines, and treat(who.int)sed to tie those two things together. (who.int) ### Why is that so hard to settle? Because it mixes science, sovereignty, and money. Countries that provide pathogen samples want guaranteed benefits in return — not vague promises. Countries with big pharmaceutical sectors want access to pathogens and data without rules they see as too rigid or too cost(who.int) equitable access. (who.int) ### What happened in Geneva? Negotiators met to finish the annex and did make progress, but they did not close the deal. WHO said member states agreed to extend the talks rather than force a bad compromise. Reuters and other coverage framed that as a delay that throws the treaty’s timeline into doubt, because the agreement cannot move ahead for signature and ratification until the annex is adopted. (who.int) ### Where does Zambia fit in? Zambia’s separate dispute with the United States is not the treaty itself, but it shows the same mistrust. Lusaka said a proposed U.S. health cooperation package worth up to $2 billion over five years was being tied to a critical-minerals deal, and it also raised concerns about data-sharing terms. That argument landed right as WHO states were fighting over whether health cooperation comes with strings attached. (usnews.com) ### Why does the annex hold up everything? Because negotiators designed the treaty so this piece comes first. One chemistry publication called the agreement “frozen in time” after adoption until the annex is done. In other words, countries agreed on the architecture last year, but the lock on the front door still has not been installed. (cen.acs.org) ### Is this just diplomatic process drama? Not really. The whole point of the treaty was to avoid the COVID pattern — countries hoarding vaccines, fighting over export controls, and treating pathogen sharing as a one-way street. If the world cannot agree on the exchange at the center of that system during peacetime, it is hard to believe(cen.acs.org)standoff points to. (who.int) ### So what happens now? More talks. WHO said states want additional time, not abandonment, and Tedros has kept pushing the line that another pandemic is inevitable. But every extension sends the same message — countries agree they need a fairer system, yet still do not trust each other enough to price the bargain. (who.int) The bottom line is simple. The world has a pandemic treaty on paper, but not yet the bargain that would make countries use it when the stakes are real. (who.int)
